questionText: To ask the Secretary of State for Health and Social Care, whether he is taking steps to licence ACT-O-VIAL containing 100mg hydrocortisone sodium succinate (powder) and 2ml of water (diluent), in the context of the discontinuation of the liquid form of hydrocortisone sodium phosphate.
answerText: The Medicines and Healthcare products Regulatory Agency (MHRA) recognises the concerns raised about the withdrawal of the previously marketed liquid hydrocortisone injection. Following a review of our current regulatory position, we can confirm that any m...
heading: Hydrocortisone